I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiom..:
Yu-jie Xing
;
Biao-hu Liu
;
Shu-jun Wan
...
https://www.frontiersin.org/articles/10.3389/fphar.2021.708177/full. , 2021
Link:
https://doi.org/10.3389/fphar.2021.708177
RT Journal T1 <Title>A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:67a70106edfb4489ac0c05135cdad8c2&Exemplar=1&LAN=DE A1 Yu-jie Xing A1 Biao-hu Liu A1 Shu-jun Wan A1 Yi Cheng A1 Si-min Zhou A1 Yue Sun A1 Xin-ming Yao A1 Qiang Hua A1 Xiang-jian Meng A1 Jin-han Cheng A1 Min Zhong A1 Yan Zhang A1 Kun Lv A1 Xiang Kong PB Frontiers Media S.A. YR 2021 K1 diabetic cardiomyopathy K1 dapagliflozin K1 oxidative stress K1 nicotinamide adenine dinucleotide phosphate oxidase K1 myocardial apoptosis K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2021.708177/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2021.708177 DO https://doi.org/10.3389/fphar.2021.708177 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
